[Osteoporosis in the elderly man].
Elderly men are at substantial risk for fracture. Morbidity after osteoporotic fractures appears to be more serious and mortality more common in men than in women. Risk factors for osteoporotic fractures in men appear to be qualitatively similar to those in women. Low bone mineral density (BMD) is an important risk factor for fracture in men; however, further clarification of the relationship between BMD, bone geometry and fracture risk is needed. Our understanding of the mechanisms underlying senile bone loss and the pathogenesis of senile osteoporosis in men remains fragmentary with, in particular, the need for further clarification regarding the precise impact of hormonal status in elderly men on skeletal homeostasis. Nevertheless, the available evidence indicates a role for both testosterone and estrogens in the regulation of bone metabolism in elderly men. Recommendations concerning prevention and treatment of senile osteoporosis in men should focus on the minimization of known risk factors for bone loss and falls. Testosterone treatment may be useful only in those men with initially low serum testosterone. As to other pharmacological treatment modalities, prospective trials specifically in elderly men, and preferably with fracture incidence as the primary clinical endpoint, are required.
Kaufman
J-M
JM
Département d'Endocrinologie et Unité d'Ostéoporose et Métabolisme Osseux, Hôpital Universitaire de Gand, De Pintelaan 185 B-9000 Gand, Belgique.
D000328:Adult; D000368:Aged; D000375:Aging; D015519:Bone Density; D001842:Bone and Bones / Q000293:injuries; D050723:Fractures, Bone / Q000453:epidemiology / Q000209:etiology; D012739:Gonadal Steroid Hormones / Q000172:deficiency; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors
D012739:Gonadal Steroid Hormones